2,000 AI-Driven, Intraoperative CT-Guided Procedures Completed with LungVision

Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced that its LungVision™ AI-driven, intraoperative CT imaging system has now been used in 2,000 diagnostic bronchoscopy procedures worldwide. Body Vision Medical’s LungVision™ System uses artificial intelligence (AI) to transform X-ray images from any C-arm into real-time, intraoperative CT scans. This empowers bronchoscopists to biopsy from smaller, more…

Read More

Desert Imaging Deploys densitas® intelliMammo™ A.I. Solutions for Breast Screening Services

Densitas® Inc., a global provider of A.I. solutions for digital mammography and breast screening announced that Desert Imaging has implemented the densitas® IntelliMammo™ platform across their health system. The adoption of intelliMammo™ reinforces Desert Imaging’s established commitment to maintaining robust organization-wide quality improvement initiatives.  IntelliMammo™ provides Desert Imaging with on-demand actionable information and streamlined workflows to establish…

Read More

NeuroLogica Announces FDA 510(k) Clearance of BodyTom® 64

NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced that its head-to-toe trauma imaging solution, the BodyTom® 64 Point-of-Care Mobile Computed Tomography (CT) Scanner, has received 510(k) clearance from the U.S. Food and Drug Administration for commercial use in the United States. “We’re thrilled to build off our expertise and elevate point-of-care imaging with…

Read More

Body Vision Medical Accelerates International Expansion with Business Asia Consultants, Inc., Partnership

Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced a new partnership with Business Asia Consultants (BAC), Inc. as part of its international expansion strategy.  BAC will apply its extensive European, Asian and Latin American market development expertise to assist Body Vision Medical in realizing its market expansion goals. “We are excited about the…

Read More

FDA Grants QT Imaging™ Clearance to Calculate Fibroglandular Volume of the Breast

The U.S. Food and Drug Administration (FDA) has granted QT Imaging, Inc. 510(K) clearance to calculate the fibroglandular volume (FGV) of the breast and the ratio of FGV to total breast volume (TGV). This ratio can contribute to an assessment of risk for breast cancer and changes in this ratio can be used to measure…

Read More

Caption Health Receives CE Mark for Caption AI™ Technology Platform

Caption Health, the leader in using AI and services to improve heart ultrasound access, announced that it has received a CE Mark for its Caption AI™ technology platform. This certification represents the first step in making Caption Health’s industry-leading technology platform available outside the US, and highlights the company’s strong clinical and regulatory track record…

Read More

annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances

annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today announced the appointment of accomplished healthcare technology executives Lakshmi Gudapakkam as Chief Executive Officer and clinical strategist Dr Rick Abramson as Chief Medical Officer. With the new appointments, annalise.ai expects to further accelerate its global market presence and entry into the US…

Read More

Saneso Novel 360° Colonoscope Receives FDA Clearance

Saneso Inc., a leading US developer of next gen endoscope systems announces today the US Food and Drug Administration (FDA) has granted 510(k) clearance of its novel integrated 360° field of view colonoscope. “We are pleased to extend the world’s first and only 360° colonoscope to all physicians, hospitals, and ASCs who will benefit from…

Read More

Invenio Imaging Receives CE Mark to Detect Cancer at the Time of Surgery using Artificial Intelligence

Invenio Imaging, the leader in intraoperative fresh tissue imaging, announced the CE Mark for the NIO Glioma Reveal image analysis module. NIO Glioma Reveal is based on deep learning and allows neurosurgeons to identify areas of cancer infiltration in patients undergoing primary treatment of a diffuse glioma. With the CE mark, neurosurgeons in the European…

Read More

iCAD’s 3D Mammography AI Improves Cancer Detection Accuracy

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, announced that new research supporting ProFound AI® for Digital Breast Tomosynthesis (DBT) will be presented at the Society of Breast Imaging (SBI/ACR) Breast Imaging Symposium, taking place May 16-19 in Savannah, GA. The Company is also showcasing its complete suite of deep-learning breast…

Read More